These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4094895)

  • 1. [Deficiency of NK activity evolving in a parallel manner with immune granulopenia].
    Thyss A; Caldani C; Bourcier C; Michiels JF; Schneider M
    Nouv Rev Fr Hematol (1978); 1985; 27(6):383-4. PubMed ID: 4094895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of natural killer cell activity in patients with immune-inflammatory diseases.
    Pedersen BK
    Dan Med Bull; 1988 Aug; 35(4):315-22. PubMed ID: 2458887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoantibodies against a 58 kD protein in neutropenia and NK cell deficiency].
    Witte T; Bode FM; Schmidt RE
    Immun Infekt; 1994 Feb; 22(1):28-9. PubMed ID: 7927461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypical and functional analyses of natural killer cells from low NK activity individuals among healthy and patient populations.
    Nagao F; Yabe T; Xu M; Okumura K
    Nat Immun; 1995 Sep; 14(5-6):225-33. PubMed ID: 8933817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
    Santoli D; Francis MK; Matera L; Ferrero D
    J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells in autoimmunity: a two-edg'd weapon of the immune system.
    Perricone R; Perricone C; De Carolis C; Shoenfeld Y
    Autoimmun Rev; 2008 May; 7(5):384-90. PubMed ID: 18486926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases.
    Masera RG; Carignola R; Staurenghi AH; Sartori ML; Lazzero A; Griot G; Angeli A
    Chronobiologia; 1994; 21(1-2):127-32. PubMed ID: 7924633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.
    Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K
    Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effector function in HLA-associated autoimmune diseases.
    Puglisi F; Capuano P; Verzillo F; Simone M; Laurentaci C; Catalano G
    Panminerva Med; 1999 Dec; 41(4):319-22. PubMed ID: 10705713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an antigen expressed by human natural killer cells.
    Griffin JD; Hercend T; Beveridge R; Schlossman SF
    J Immunol; 1983 Jun; 130(6):2947-51. PubMed ID: 6574190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is agranulocytosis following infectious mononucleosis caused by autoimmunity?
    Auvin S; Dalle JH; Ganga-Zandzou PS; Ythier H
    Pediatr Hematol Oncol; 2003 Dec; 20(8):611-5. PubMed ID: 14578031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells in human autoimmunity.
    Flodström-Tullberg M; Bryceson YT; Shi FD; Höglund P; Ljunggren HG
    Curr Opin Immunol; 2009 Dec; 21(6):634-40. PubMed ID: 19892538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
    J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer (NK) cell activity during lymphatic regeneration: early appearance of Thy-1+ NK cells and highly interleukin 2-(IL 2) receptive, Thy-1- cells.
    Hurme M; Sihvola M
    J Immunol; 1983 Aug; 131(2):658-61. PubMed ID: 6134773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of millimeter waves on natural killer cell activation.
    Makar VR; Logani MK; Bhanushali A; Kataoka M; Ziskin MC
    Bioelectromagnetics; 2005 Jan; 26(1):10-9. PubMed ID: 15605409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells.
    Kitaichi N; Kotake S; Morohashi T; Onoé K; Ohno S; Taylor AW
    J Leukoc Biol; 2002 Dec; 72(6):1117-21. PubMed ID: 12488492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.